Study to Evaluate the Pharmacokinetic Characteristics of Luckyvec 400mg Tablet, in Healthy Subjects

Inclusion Criteria: * Between 20 aged and 45 aged in healthy males * BMI: 18\~29.9 kg/m2, (BMI = (체중 \[kg\])/(height \[m\])2) * Agreement with written informed consent Exclusion Criteria: * Clinically significant cardiovascular system, pulmonary system, liver system, renal system, blood system, gastrointestinal system, immune system, skin system, nervous system or mental disease(Past history or present) * Subject with symptoms of acute disease within 28 days of starting administration of investigational drug * Subject with known for history which affect on the ADME of drug * Clinically significant active chronic disease * Inadequate result of laboratory test * AST/ALT \> 1.5 x UNL * Total bilirubin \> 1.5 x UNL * Positive reaction in the HBs Ag, anti-HCV Ab, anti-HIV Ab, VDRL test * Taking ETC(ethical the counter)medicine within 14 days * Taking OTC(Over the counter)medicine including oriental medicine within 7 days * Clinically significant allergic disease(Except for mild allergic rhinitis and dermatits seems to be not need for medication) * Subject with known for hypersensitivity reaction to imatinib analog * Not able to taking the institutional standard meal * Previously make whole blood donation within 60 days or component blood donation within 20 days * Previously have blood transfusion within 30 days * Previously participated in other trial within 30 days * Continued to be taking caffeine (caffeine \> 5 cup/day), drinking(alcohol \> 30 g/day) and severe heavy smoker (cigarette \> 1/2 pack per day) * An impossible one who participates in clinical trial by investigator's decision including for reason of laboratory test result